Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench

Clin Neurol Neurosurg. 2004 Jun;106(3):270-4. doi: 10.1016/j.clineuro.2004.02.013.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alemtuzumab
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / pharmacology
  • Antibodies, Neoplasm / therapeutic use*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • CD4 Antigens / drug effects
  • CD8 Antigens / drug effects
  • Cohort Studies
  • Disease Progression
  • Female
  • Humans
  • Male
  • Multiple Sclerosis / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • CD4 Antigens
  • CD8 Antigens
  • Alemtuzumab